Cargando…

Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease

BACKGROUND: Serum pepsinogen (PG) I/II ratio has been widely used as “serological biopsy” for the screening of gastric cancer (GC) and atrophic gastritis (GA). However, study concerning in situ expression of PGs is currently insufficient, particularly for their relationship with serum PGs levels. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, He, Caiyun, Sun, Liping, Dong, Nannan, Yuan, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846408/ https://www.ncbi.nlm.nih.gov/pubmed/24004680 http://dx.doi.org/10.1186/1472-6890-13-22

Ejemplares similares

Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer
por: Wang, Yaping, et al.
Publicado: (2020)

Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
por: Cha, Jae Hwang, et al.
Publicado: (2020)

Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer
por: Miki, Kazumasa, et al.
Publicado: (1993)

Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases
por: Jiang, Jingyi, et al.
Publicado: (2018)

Pepsinogen I and II, Gastrin and Cag A Serum Levels in Shiraz
por: Shamsdin, Seyedeh Azra, et al.
Publicado: (2011)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
por: Razuka-Ebela, Danute, et al.
Publicado: (2022)

Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
por: Hosseini, Mosalreza, et al.
Publicado: (2013)

Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
por: Qin, Yuan, et al.
Publicado: (2023)

Pepsinogens I and II in Gastric Cancer: An Immunohistochemical Study Using Monoclonal Antibodies
por: Huang, Shih Che, et al.
Publicado: (1988)

Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis
por: Chen, Lingli, et al.
Publicado: (2021)

The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer
por: Juan Cai, Wei, et al.
Publicado: (2017)

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020)

Gastric neoplasms and pepsinogen phenotypes.
por: Ellis, A., et al.
Publicado: (1982)

Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area
por: Yuan, Lin, et al.
Publicado: (2020)

Tea Polyphenol Intake and Changes in Serum Pepsinogen Levels
por: Hamajima, Nobuyuki, et al.
Publicado: (1999)

Low Pepsinogen I Level Predicts Multiple Gastric Epithelial Neoplasias for Endoscopic Resection
por: Park, Seon-Young, et al.
Publicado: (2014)

PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases
por: Ning, Peifang, et al.
Publicado: (2020)

Effect of Smoking on Serum Pepsinogen I Level Depends on Serological Status of Helicobacter pylori
por: Tatemichi, Masayuki, et al.
Publicado: (2001)

The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China
por: Zhang, Xiao-mei, et al.
Publicado: (2014)

Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer
por: Alikhani, Mehdi, et al.
Publicado: (2021)

Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2022)

Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic
por: Igarashi, Muneki, et al.
Publicado: (2014)

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population
por: Cai, Hao-Lei, et al.
Publicado: (2021)

The panoramic picture of pepsinogen gene family with pan‐cancer
por: Shen, Shixuan, et al.
Publicado: (2020)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
por: Hattori, Yasushi, et al.
Publicado: (1995)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors
por: Magris, Raffaella, et al.
Publicado: (2020)

Association Between Serum Midkine Level and Gastric Precancerous Lesion in Patients with Gastritis
por: Siregar, Jelita, et al.
Publicado: (2022)

Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
por: Miftahussurur, Muhammad, et al.
Publicado: (2020)

The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
por: Shen, Hongzhang, et al.
Publicado: (2021)

Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study
por: Tong, Yuling, et al.
Publicado: (2021)

Accuracy and Cut-Off Values of Pepsinogens I, II and Gastrin 17 for Diagnosis of Gastric Fundic Atrophy: Influence of Gastritis
por: Nasrollahzadeh, Dariush, et al.
Publicado: (2011)

Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor
por: Yada, Tomoyuki, et al.
Publicado: (2014)

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
por: Yu, Hong, et al.
Publicado: (2021)

Pepsinogen and Pepsin
por: Herriott, Roger M.
Publicado: (1962)

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”
por: MIKI, Kazumasa
Publicado: (2011)

The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case–control study in Korea
por: Cho, Jun-Hyung, et al.
Publicado: (2017)

Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case–control study
por: Xu, Qian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k4vpig488o9lcr22lm1sbi1s42